ADHD in the News

ADHD in the News 2023-11-30

December 1, 2023

Shortage of Adderall and other ADHD drugs expected to last through 2024, despite federal attempts to fix it

Longer Use of ADHD Meds May Boost Heart Risk — Observational data suggest particular risk for hypertension and arterial disease

People taking ADHD medications should closely monitor their heart health, study suggests

View

ADHD in the News 2023-11-16

November 16, 2023

Can’t Think, Can’t Remember: More Americans Say They’re in a Cognitive Fog

ADHD drugs delay bone healing in children, UB researchers report

Substituting ADHD Medications During the Stimulant Shortage

View

ADHD in the News 2023-11-09

November 9, 2023

Annual International Conference on ADHD Hosted by CHADD, ADDA and ACO Provides Practical Support and Guidance for the ADHD Community

Adderall makers agree to increase production: DEA

Underdiagnosed and undertreated, young Black males with ADHD get left behind

View

ADHD in the News 2023-11-02

November 2, 2023

William Pelham Jr., a groundbreaking researcher in children’s ADHD, dies at 75 in Miami

Youngest children in class with ADHD as likely to keep diagnosis in adulthood as older pupils, find scientists

New genes linked to ADHD identified, potentially paving the way for new treatments

View

ADHD in the News 2023-10-26

October 26, 2023

New distractibility ‘d factor’ may be linked with ADHD

Study challenges link between low birth weight and childhood neurodevelopmental issues

A Revolutionary Peek at the Noradrenaline System

View

ADHD in the News 2023-10-19

October 19, 2023

Adults with ADHD are at increased risk for developing dementia

Craig Surman, MD: Sleep Drug Solriamfetol Can Effectively Treat ADHD

Overtalking may signal a mental health condition

View

ADHD in the News 2023-10-12

October 12, 2023

Narcolepsy Drug Might Be New Treatment Option for ADHD

The A.D.H.D. Drug Shortage Is Causing Real Pain (Opinion)

ADHD Appears Underdiagnosed in Patients at a Pediatric Headache Clinic

View

ADHD in the News 2023-10-05

October 5, 2023

FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders

DEA Loosens ADHD Drug Production Controls Amid Shortage

Study: Prevalence of ADHD was steady during the pandemic

View

ADHD in the News 2023-09-28

September 28, 2023

Scientists find new evidence to explain how we pay attention

DEA Gets an Earful About Telehealth Prescribing of Controlled Substances — Proposed in-person visit requirements raises concern for psychiatry groups

Signs you might be struggling with emotional dysregulation, according to 2 therapists

View

ADHD in the News 2023-09-21

September 21, 2023

Study shows nearly 300% increase in ADHD medication errors

People over 50 with ADHD ‘overlooked’ for diagnosis and treatment, say experts

Positive Top-Line Phase 3 Data on Novel ADHD Treatment, CTx-1301

View

ADHD in the News 2023-09-14

September 14, 2023

ADHD medications still in shortage, frustrating patients and doctors

Understanding the unique challenges of adult ADHD

ADHD Drug Shortages Worsen as Makers Say Production Is Maxed Out

View

ADHD in the News 2023-09-07

September 7, 2023

ADHD: A risk factor for serious mental health issues, research finds

Generic drugmakers start shipping copies of Takeda’s ADHD drug Vyvanse

ADHD drug shortage stresses families during back-to-school season

View
Page 2 of 36